BioNTech SE (BNTX)
92.17
-0.11
(-0.12%)
USD |
NASDAQ |
May 15, 16:00
92.17
0.00 (0.00%)
After-Hours: 16:25
BioNTech Price to Book Value: 1.030 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 1.031 |
| May 13, 2024 | 1.036 |
| May 10, 2024 | 1.024 |
| May 09, 2024 | 1.029 |
| May 08, 2024 | 1.007 |
| May 07, 2024 | 1.016 |
| May 06, 2024 | 1.043 |
| May 03, 2024 | 1.036 |
| May 02, 2024 | 1.031 |
| May 01, 2024 | 1.005 |
| April 30, 2024 | 0.9926 |
| April 29, 2024 | 0.9829 |
| April 26, 2024 | 0.9746 |
| April 25, 2024 | 0.9691 |
| April 24, 2024 | 0.9845 |
| April 23, 2024 | 0.9889 |
| April 22, 2024 | 0.9836 |
| April 19, 2024 | 0.9702 |
| April 18, 2024 | 0.963 |
| April 17, 2024 | 0.9656 |
| April 16, 2024 | 0.9649 |
| April 15, 2024 | 0.9822 |
| April 12, 2024 | 0.9665 |
| April 11, 2024 | 0.9724 |
| April 10, 2024 | 0.9907 |
| Date | Value |
|---|---|
| April 09, 2024 | 1.006 |
| April 08, 2024 | 0.9981 |
| April 05, 2024 | 0.9979 |
| April 04, 2024 | 0.9915 |
| April 03, 2024 | 1.001 |
| April 02, 2024 | 1.009 |
| April 01, 2024 | 1.027 |
| March 31, 2024 | |
| March 28, 2024 | 0.9799 |
| March 27, 2024 | 0.9876 |
| March 26, 2024 | 0.9741 |
| March 25, 2024 | 0.9879 |
| March 22, 2024 | 0.9754 |
| March 21, 2024 | 0.9771 |
| March 20, 2024 | 0.956 |
| March 19, 2024 | 0.9998 |
| March 18, 2024 | 0.9878 |
| March 15, 2024 | 0.9824 |
| March 14, 2024 | 0.9869 |
| March 13, 2024 | 0.998 |
| March 12, 2024 | 1.017 |
| March 11, 2024 | 1.023 |
| March 08, 2024 | 0.9695 |
| March 07, 2024 | 0.9676 |
| March 06, 2024 | 0.9708 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.945
Minimum
Feb 29 2024
37.74
Maximum
Mar 18 2020
8.733
Average
3.142
Median
Mar 18 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.769 |
| Moderna Inc | 3.859 |
| Novavax Inc | -- |
| GSK PLC | 5.333 |
| BioVie Inc | 2.642 |
Price to Book Value Related Metrics
| PE Ratio | 191.83 |
| PS Ratio | 7.500 |
| Price to Free Cash Flow | 4.146 |
| Price | 92.17 |
| Earnings Yield | 0.52% |
| Market Cap | 22.21B |
| Normalized PE Ratio | 133.64 |